Release Date: 24/11/22 18:16 Summary: Chairman's Address Annual General Meeting Price Sensitive: No Download Document 348.8KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%